January 8, 2019
Lupin gets first EU licensed treatment in EU for myotonia in adults, hits UK German markets in Q1 2019
Lupin got the EC approval of NaMuscla for reducing myotonia symptoms in adult patients, and has partnering discussions ongoing for commercialization of NaMuscla in European territories outside Germany and the UK.